Search Results 1201-1210 of 14754 for anti-TNF drugs

1. Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression - Mayo Clinic

   This study is designed to answer whether patients with progressive IgA nephropathy, who receive Acthar (ACTH) gel injection at a dose of 80 units subcutaneously ...

2. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

   By condition, treatment or drug name. Search ... - Belimumab, telitacicept, abatacept, TNF-? mAb ... anti-TB treatment, participants with history of ...

3. TKA and THA for patients with previous solid organ transplant - Mayo Clinic

   Patients must optimize anti-rejection medications prior to joint surgery, under careful supervision of the medical transplant physician. Rapid dismissal.

4. A Study to Assess Therapeutic Hypothermia to Cool Injured Legs in Patients with Acute Respiratory Distress Syndrome - Mayo Clinic

   By condition, treatment or drug name. Search tips. A Study to ... Mild hypothermia increases pulmonary anti ... Delaying HS for 3 hours after TNF-α treatment ...

5. Tacrolimus (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Antihemophilic Factor Viii And Von Willebrand Factor (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Etranacogene Dezaparvovec-Drlb (Intravenous Route) Description and Brand Names - Mayo Clinic

   Etranacogene dezaparvovec-drlb injection is used to treat hemophilia B (congenital Factor IX deficiency) in patients who are using Factor IX treatment, have ...

8. RO7247669 Combined With Nab-Paclitaxel Compared With Pembrolizumab Combined With Nab-Paclitaxel for Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   ... anti-TNF agents) within 2 weeks prior to initiation of study treatment: Participants who have received acute, low-dose, systemic immunosuppressant medications ...

9. Toremifene (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

10. Pentostatin (Intravenous Route) Side Effects - Mayo Clinic

    Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or ...